
Rayonier Advanced Materials, Inc. Experiences Evaluation Revision Amid Market Dynamics and Performance Metrics
2025-10-07 20:14:36Rayonier Advanced Materials, Inc. has recently revised its evaluation amid fluctuating stock prices, closing at $7.71. The company has experienced significant volatility over the past year. Technical indicators present a mixed outlook, while performance comparisons with the S&P 500 reveal both strengths and challenges in its market position.
Read More
Rayonier Advanced Materials Forms Golden Cross, Signals Bullish Breakout Ahead
2025-10-06 15:25:45Rayonier Advanced Materials, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock outperformed the S&P 500 today and has shown a strong upward trend over the past week and month, despite a challenging one-year performance. Its market cap is around $460 million.
Read MoreIs Rayonier Advanced Materials, Inc. technically bullish or bearish?
2025-09-20 19:56:07As of 11 September 2025, the technical trend for Rayonier Advanced Materials, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is bullish, while the monthly MACD is bearish. The weekly RSI is bearish, and the daily moving averages indicate a mildly bearish trend. However, both the weekly and monthly Bollinger Bands are bullish, and the KST shows a bullish weekly signal but mildly bearish monthly. Dow Theory and OBV are both mildly bullish on a weekly and monthly basis. In terms of performance, the stock has shown a strong 1-week return of 16.12% compared to the S&P 500's 1.05%, and a notable 1-month return of 38.72% against the S&P 500's 2.33%. However, over longer periods, the stock has underperformed the benchmark, with a year-to-date return of -13.58% compared to the S&P 500's 12.22%....
Read MoreIs Rayonier Advanced Materials, Inc. overvalued or undervalued?
2025-09-20 18:29:58As of 7 November 2023, the valuation grade for Rayonier Advanced Materials, Inc. has moved from attractive to risky, indicating a shift in perception regarding its investment potential. The company appears to be overvalued based on its current financial metrics, particularly given its negative P/E ratio and ROE of -1.34%. Key ratios include a Price to Book Value of 0.38, an EV to EBITDA of 4.58, and an EV to Sales of 0.55, which suggest that the company is trading at a significant discount relative to its sales and earnings potential, yet the overall financial health raises concerns. In comparison to peers, Westlake Chemical Partners LP, which is rated very attractive, has a P/E ratio of 2.42 and an EV to EBITDA of 2.50, highlighting a stark contrast in valuation and performance. Similarly, Mativ Holdings, Inc. is also rated risky with a P/E of -22.21 and an EV to EBITDA of 9.54, further emphasizing the ch...
Read More





